Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Losartan on Cognitive Flexibility and Learning
NCT06628154Phase 1Recruiting
- Sponsor
- University of Oxford
- Start
- Aug 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anxiety disorder, major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) comparing Losartan Arm with Placebo Arm (2 arms). Primary endpoint: Reinforcement Learning at 1 hour. Started Aug 2024; status: recruiting.
02
Drugs
losartan
03
Conditions
anxiety disordermajor depressive disorder (MDD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06628154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06628154.